These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24430184)

  • 1. Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.
    Li H; Tan M; Jia L; Wei D; Zhao Y; Chen G; Xu J; Zhao L; Thomas D; Beer DG; Sun Y
    J Clin Invest; 2014 Feb; 124(2):835-46. PubMed ID: 24430184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization.
    Tan M; Li H; Sun Y
    Neoplasia; 2015 Jan; 17(1):114-23. PubMed ID: 25622904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
    Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
    J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
    Tan M; Li Y; Yang R; Xi N; Sun Y
    PLoS One; 2011; 6(11):e27726. PubMed ID: 22110742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.
    Jia L; Yang J; Hao X; Zheng M; He H; Xiong X; Xu L; Sun Y
    Clin Cancer Res; 2010 Feb; 16(3):814-24. PubMed ID: 20103673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
    Tan M; Li H; Sun Y
    Oncogene; 2014 Oct; 33(44):5211-20. PubMed ID: 24213570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.
    Sun Y; Li H
    Protein Cell; 2013 Feb; 4(2):103-16. PubMed ID: 23136067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model.
    Tan M; Chang Y; Liu X; Li H; Tang Z; Nyati MK; Sun Y
    Cell Rep; 2022 Dec; 41(12):111837. PubMed ID: 36543126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model.
    Zhang Q; Wei D; Tan M; Li H; Morgan MA; Sun Y
    Neoplasia; 2020 Apr; 22(6):242-252. PubMed ID: 32339950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
    Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
    Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
    Gu Q; Tan M; Sun Y
    Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.
    Tan M; Zhao Y; Kim SJ; Liu M; Jia L; Saunders TL; Zhu Y; Sun Y
    Dev Cell; 2011 Dec; 21(6):1062-76. PubMed ID: 22118770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
    Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
    Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
    [No Abstract]   [Full Text] [Related]  

  • 15. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.
    Gu Q; Bowden GT; Normolle D; Sun Y
    J Cell Biol; 2007 Sep; 178(6):1009-23. PubMed ID: 17846172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements and perspectives of RBX2 as a molecular hallmark in cancer.
    Tao Y; Dai L; Liang W; Li X; Lyu Y; Li J; Li Z; Shi Z; Liang X; Zhou S; Fu X; Hu W; Wang X
    Gene; 2024 Jan; 892():147864. PubMed ID: 37820940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation.
    Duan H; Tsvetkov LM; Liu Y; Song Y; Swaroop M; Wen R; Kung HF; Zhang H; Sun Y
    Mol Carcinog; 2001 Jan; 30(1):37-46. PubMed ID: 11255262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
    Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
    Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.
    Wei D; Sun Y
    Genes Cancer; 2010 Jul; 1(7):700-7. PubMed ID: 21103004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.